Jeremy D Wright

6395292, May 28, 2002

May 4, 2001

09/848211

John R. Peery - Stanford CA
Keith E. Dionne - Menlo Park CA
James B. Eckenhoff - Los Altos CA
Felix A. Landrau - Punta Gorda FL
Scott D. Lautenbach - San Mateo CA
Judy A. Magruder - Mountain View CA
Jeremy C. Wright - Los Altos CA

Alza Corporation - Mountain View CA

A61F 200

424422, 424423, 424424, 6048911, 5147723, 514781

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

6635268, Oct 21, 2003

Mar 28, 2002

10/108303

John R. Peery - Stanford CA
Keith E. Dionne - Menlo Park CA
James B. Eckenhoff - Los Altos CA
Felix A. Landrau - Punta Gorda FL
Scott D. Lautenbach - San Mateo CA
Judy A. Magruder - Mountain View CA
Jeremy C. Wright - Los Altos CA

Alza Corporation - Mountain View CA

A61F 200

424422, 424423, 424424, 6048911, 6048921

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

6872292, Mar 29, 2005

Jan 28, 2003

10/353770

Felix Theeuwes - Los Altos CA, US
Jeremy Corwin Wright - Los Altos CA, US

Microlin, L.C. - Salt Lake City UT

B01D061/44
A61N001/30

204520, 204630, 604 20

An electro-osmotic cell capable of substantially reducing zero-current transport is disclosed, wherein the cell includes a cell housing having a first half cell and a second half cell, with an ion selective membrane therebetween, a first electrode positioned within the first half cell, a second electrode positioned within the second half cell, an electrolyte in electrical communication with the first electrode and the second electrode, and a wiring apparatus electrically connecting the first electrode and the second electrode, wherein the wiring apparatus has one or more structures used for counteracting salt concentration increases within the electro-osmotic cell. Such a cell may be used within an electro-osmotic fluid delivery device, along with a fluid inlet, a piston member adjacent the electro osmotic cell, and a drug reservoir adjacent the piston member, wherein the drug reservoir includes a sealed compartment having an exit port. A method for using such a device is similarly disclosed.

7371229, May 13, 2008

Jan 28, 2003

10/353769

Felix Theeuwes - Los Altos CA, US
Jeremy Corwin Wright - Los Altos CA, US

A61K 9/22

6048921

The present invention is disclosed herein as an electrochemical cell having a cell housing with a first half cell and a second half cell, and an ion selective membrane between the cells. The electrochemical cell further has a first electrode positioned within the first half cell, a second electrode positioned within the second half cell, an electrolyte in electrical communication with both the first electrode and the second electrode. The electrodes of the cell are configured so that the electrochemical cell maintains a substantially constant salt concentration level throughout operation. The cell is preferably used in conjunction with an implantable fluid delivery apparatus. A method for using the device is additionally disclosed.

7655257, Feb 2, 2010

Aug 20, 2003

10/645293

John R. Peery - Stanford CA, US
Keith E. Dionne - Menlo Park CA, US
James B. Eckenhoff - Los Altos CA, US
Felix A. Landrau - Punta Gorda FL, US
Scott D. Lautenbach - San Mateo CA, US
Judy A. Magruder - Mountain View CA, US
Jeremy C. Wright - Los Altos CA, US

Intarcia Therapeutics, Inc. - Hayward CA

A61K 9/20
A61K 9/22
A61K 9/24

424473, 424422, 424484, 6048911, 604890, 604 1

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

8080259, Dec 20, 2011

Dec 29, 2009

12/655399

John R. Peery - Stanford CA, US
Keith E. Dionne - Menlo Park CA, US
James B. Eckenhoff - Los Altos CA, US
Felix A. Landrau - Punta Gorda FL, US
Scott D. Lautenbach - San Mateo CA, US
Judy A. Magruder - Mountain View CA, US
Jeremy C. Wright - Los Altos CA, US

Intarcia Therapeutics, Inc. - Hayward CA

A61K 9/20
A61K 9/22
A61K 9/24
A61F 2/00

424422, 6048911

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

8298562, Oct 30, 2012

May 26, 2011

13/116970

John R. Peery - Stanford CA, US
Keith E. Dionne - Menlo Park CA, US
James B. Eckenhoff - Los Altos CA, US
Felix A. Landrau - Punta Gorda FL, US
Scott D. Lautenbach - San Mateo CA, US
Judy A. Magruder - Mountain View CA, US
Jeremy C. Wright - Los Altos CA, US

Intarcia Therapeutics, Inc. - Hayward CA

A61K 9/20
A61K 9/22
A61K 9/24
A61F 2/00

424422, 6048911

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

8501215, Aug 6, 2013

Jul 28, 2003

10/628984

Guohua Chen - Sunnyvale CA, US
Paul Houston - Hayward CA, US
Lothar Kleiner - Los Altos CA, US
Jeremy Wright - Los Altos CA, US

A61F 2/00
A61F 13/00
A61K 9/14

424426, 424422, 424487

Injectable depot compositions are provided that include a polymer matrix having a plurality of bioerodible, biocompatible polymers wherein each polymer of the plurality of polymers has a specified average molecular weight, and the polymer matrix has a broad molecular weight distribution of the plurality of polymers; a solvent having a miscibility in water of less than or equal to 7 wt % at 25 C. , in an amount effective to plasticize the polymer and form a gel therewith; and a beneficial agent. The compositions have substantially improved shear thinning behavior and reduced injection force, rendering the compositions readily implanted beneath a patient's body surface by injection.